foscarnet has been researched along with Hematologic Neoplasms in 6 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An unusually high incidence of acyclovir- and foscarnet-resistant herpes simplex virus (HSV) infection was noted after lymphocyte-depleted blood hematopoietic progenitor cell (HPC) transplantation from HLA-haploidentical family donors." | 3.71 | Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. ( Allen, A; Bucur, S; Caliendo, AM; Cherry, J; Hutcherson, D; Langston, AA; Lonial, S; Redei, I; Somani, J; Waller, EK, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, HC | 1 |
| Liu, WD | 1 |
| Kuo, PH | 1 |
| Lin, CC | 1 |
| Wu, UI | 1 |
| Didsbury, MS | 1 |
| Mackie, FE | 1 |
| Kennedy, SE | 1 |
| Hebart, H | 1 |
| Brugger, W | 1 |
| Grigoleit, U | 1 |
| Gscheidle, B | 1 |
| Loeffler, J | 1 |
| Schäfer, H | 1 |
| Kanz, L | 1 |
| Einsele, H | 1 |
| Sinzger, C | 1 |
| Kiehl, MG | 1 |
| Basara, N | 1 |
| Chakrabarti, S | 1 |
| Collingham, KE | 1 |
| Osman, H | 1 |
| Fegan, CD | 1 |
| Milligan, DW | 1 |
| Langston, AA | 1 |
| Redei, I | 1 |
| Caliendo, AM | 1 |
| Somani, J | 1 |
| Hutcherson, D | 1 |
| Lonial, S | 1 |
| Bucur, S | 1 |
| Cherry, J | 1 |
| Allen, A | 1 |
| Waller, EK | 1 |
1 review available for foscarnet and Hematologic Neoplasms
| Article | Year |
|---|---|
A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients.
Topics: Acute Kidney Injury; Adolescent; Amphotericin B; Biomarkers; Child; Cyclosporine; Foscarnet; Glomeru | 2015 |
1 trial available for foscarnet and Hematologic Neoplasms
| Article | Year |
|---|---|
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, | 2001 |
4 other studies available for foscarnet and Hematologic Neoplasms
| Article | Year |
|---|---|
Cutaneous presentation of disseminated cytomegalovirus infection in a non-transplant patient with hematological malignancy: A case report.
Topics: Antiviral Agents; Cytomegalovirus Infections; Fatal Outcome; Foscarnet; Ganciclovir; Hematologic Neo | 2022 |
Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; F | 2001 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos | 2001 |
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Haplotypes; Hematolog | 2002 |